Cheryl Barnabe1, Brenda Hemmelgarn2, C Allyson Jones2, Christine A Peschken2, Don Voaklander2, Lawrence Joseph2, Sasha Bernatsky2, John M Esdaile2, Deborah A Marshall2. 1. From the Department of Medicine and Department of Community Health Sciences, University of Calgary, Calgary; Department of Physical Therapy, and School of Public Health, University of Alberta, Edmonton, Alberta; Department of Medicine, and Department of Community Health Sciences, University of Manitoba, Winnipeg, Manitoba; University of British Columbia, Vancouver; Arthritis Research Centre of Canada, Richmond, British Columbia; Divisions of Clinical Epidemiology and Rheumatology, Research Institute of the McGill University Health Centre, and Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada.C. Barnabe, MD, MSc, FRCPC, Assistant Professor; B. Hemmelgarn, MD, PhD, FRCPC, Professor; D.A. Marshall, PhD, Associate Professor, Department of Medicine and Department of Community Health Sciences, University of Calgary; C.A. Jones, MSc(PT), PhD, Associate Professor, Department of Physical Therapy and School of Public Health; D. Voaklander, PhD, Professor, School of Public Health, University of Alberta; C.A. Peschken, MD, MSc, FRCPC, Associate Professor, Department of Medicine and Department of Community Health Sciences, University of Manitoba; L. Joseph, PhD, Professor, Division of Clinical Epidemiology, Research Institute of the McGill University Health Centre, and Department of Epidemiology, Biostatistics and Occupational Health, McGill University; S. Bernatsky, MD, PhD, FRCPC, Associate Professor, Divisions of Clinical Epidemiology and Rheumatology, Research Institute of the McGill University Health Centre; J.M. Esdaile, MD, MPH, FRCPC, Professor, University of British Columbia, Arthritis Research Centre of Canada. ccbarnab@ucalgary.ca. 2. From the Department of Medicine and Department of Community Health Sciences, University of Calgary, Calgary; Department of Physical Therapy, and School of Public Health, University of Alberta, Edmonton, Alberta; Department of Medicine, and Department of Community Health Sciences, University of Manitoba, Winnipeg, Manitoba; University of British Columbia, Vancouver; Arthritis Research Centre of Canada, Richmond, British Columbia; Divisions of Clinical Epidemiology and Rheumatology, Research Institute of the McGill University Health Centre, and Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada.C. Barnabe, MD, MSc, FRCPC, Assistant Professor; B. Hemmelgarn, MD, PhD, FRCPC, Professor; D.A. Marshall, PhD, Associate Professor, Department of Medicine and Department of Community Health Sciences, University of Calgary; C.A. Jones, MSc(PT), PhD, Associate Professor, Department of Physical Therapy and School of Public Health; D. Voaklander, PhD, Professor, School of Public Health, University of Alberta; C.A. Peschken, MD, MSc, FRCPC, Associate Professor, Department of Medicine and Department of Community Health Sciences, University of Manitoba; L. Joseph, PhD, Professor, Division of Clinical Epidemiology, Research Institute of the McGill University Health Centre, and Department of Epidemiology, Biostatistics and Occupational Health, McGill University; S. Bernatsky, MD, PhD, FRCPC, Associate Professor, Divisions of Clinical Epidemiology and Rheumatology, Research Institute of the McGill University Health Centre; J.M. Esdaile, MD, MPH, FRCPC, Professor, University of British Columbia, Arthritis Research Centre of Canada.
Abstract
OBJECTIVE: To estimate the population-based prevalence and healthcare use for osteoarthritis (OA) by First Nations (FN) and non-First Nations (non-FN) in Alberta, Canada. METHODS: A cohort of adults with OA (≥ 2 physician claims in 2 yrs or 1 hospitalization with ICD-9-Clinical Modification code 715x or ICD-10-Canadian Adaptation code M15-19, 1993-2010) was defined with FN determination by premium payer status. Prevalence rates (2007/8) were estimated from the cohort and the population registered with the Alberta Health Care Insurance Plan. Rates of outpatient primary care and specialist visits (orthopedics, rheumatology, internal medicine), arthroplasty (hip and knee), and all-cause hospitalization were estimated. RESULTS: OA prevalence in FN was twice that of the non-FN population [16.1 vs 7.8 cases/100 population, standardized rate ratio (SRR) adjusted for age and sex 2.06, 95% CI 2.00-2.12]. The SRR (adjusted for age, sex, and location of residence) for primary care visits for OA was nearly double in FN compared with non-FN (SRR 1.88, 95% CI 1.87-1.89), and internal medicine visits were increased (SRR 1.25, 95% CI 1.25-1.26). Visit rates with an orthopedic surgeon (SRR 0.49, 95% CI 0.48-0.50) or rheumatologist (SRR 0.62, 95% CI 0.62-0.63) were substantially lower in FN with OA. Hip and knee arthroplasties were performed less frequently in FN with OA (SRR 0.48, 95% CI 0.47-0.49), but all-cause hospitalization rates were higher (SRR 1.59, 95% CI 1.58-1.60). CONCLUSION: We estimate a 2-fold higher prevalence of OA in the FN population with differential healthcare use. Reasons for higher use of primary care and lower use of specialty services and arthroplasty compared with the general population are not yet understood.
OBJECTIVE: To estimate the population-based prevalence and healthcare use for osteoarthritis (OA) by First Nations (FN) and non-First Nations (non-FN) in Alberta, Canada. METHODS: A cohort of adults with OA (≥ 2 physician claims in 2 yrs or 1 hospitalization with ICD-9-Clinical Modification code 715x or ICD-10-Canadian Adaptation code M15-19, 1993-2010) was defined with FN determination by premium payer status. Prevalence rates (2007/8) were estimated from the cohort and the population registered with the Alberta Health Care Insurance Plan. Rates of outpatient primary care and specialist visits (orthopedics, rheumatology, internal medicine), arthroplasty (hip and knee), and all-cause hospitalization were estimated. RESULTS: OA prevalence in FN was twice that of the non-FN population [16.1 vs 7.8 cases/100 population, standardized rate ratio (SRR) adjusted for age and sex 2.06, 95% CI 2.00-2.12]. The SRR (adjusted for age, sex, and location of residence) for primary care visits for OA was nearly double in FN compared with non-FN (SRR 1.88, 95% CI 1.87-1.89), and internal medicine visits were increased (SRR 1.25, 95% CI 1.25-1.26). Visit rates with an orthopedic surgeon (SRR 0.49, 95% CI 0.48-0.50) or rheumatologist (SRR 0.62, 95% CI 0.62-0.63) were substantially lower in FN with OA. Hip and knee arthroplasties were performed less frequently in FN with OA (SRR 0.48, 95% CI 0.47-0.49), but all-cause hospitalization rates were higher (SRR 1.59, 95% CI 1.58-1.60). CONCLUSION: We estimate a 2-fold higher prevalence of OA in the FN population with differential healthcare use. Reasons for higher use of primary care and lower use of specialty services and arthroplasty compared with the general population are not yet understood.
Entities:
Keywords:
AMERICAN NATIVE CONTINENTAL ANCESTRY GROUP; EPIDEMIOLOGY; HEALTH SERVICES RESEARCH; OSTEOARTHRITIS
Authors: Samantha Slight-Webb; Carla J Guthridge; Joseph Kheir; Hua Chen; Ly Tran; Tim Gross; Virginia Roberts; Sohail Khan; Michael Peercy; Bobby Saunkeah; Joel M Guthridge; Judith A James Journal: Arthritis Care Res (Hoboken) Date: 2021-10-01 Impact factor: 4.794
Authors: Penny O'Brien; Samantha Bunzli; Ivan Lin; Tilini Gunatillake; Dawn Bessarab; Juli Coffin; Gail Garvey; Michelle Dowsey; Peter Choong Journal: J Clin Med Date: 2020-07-27 Impact factor: 4.241
Authors: Jason A McVicar; Alana Poon; Nadine R Caron; M Dylan Bould; Jason W Nickerson; Nora Ahmad; Donna May Kimmaliardjuk; Chelsey Sheffield; Caitlin Champion; Daniel I McIsaac Journal: CMAJ Date: 2021-05-17 Impact factor: 8.262
Authors: Jason A McVicar; Alana Poon; Nadine R Caron; M Dylan Bould; Jason W Nickerson; Nora Ahmad; Donna May Kimmaliardjuk; Chelsey Sheffield; Caitlin Champion; Daniel I McIsaac Journal: CMAJ Date: 2021-08-23 Impact factor: 8.262
Authors: Kai Karos; Joanna L McParland; Samantha Bunzli; Hemakumar Devan; Adam Hirsh; Flavia P Kapos; Edmund Keogh; David Moore; Lincoln M Tracy; Claire E Ashton-James Journal: Pain Date: 2020-10 Impact factor: 7.926